As NLRP3 inflammasome activity has been linked to many diseases and disorders, the identification of INPP5D as a member of this pathway would have therapeutic significance in other disease fields beyond Alzheimer’s disease. This evidence concerns the gene INPP5D and early-onset autosomal dominant Alzheimer disease.